查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1564094

X 射线结晶的全球市场

X-Ray Crystallography
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球 X 光结晶市场预计将达到 20 亿美元

全球X射线结晶市场预估2023年为9.373亿美元，预估至2030年将达20亿美元，2023-2030年分析期间复合年增长率为11.4%。药品最终用途是本报告分析的细分市场之一，预计复合年增长率为 10.9%，到分析期结束时将达到 9.445 亿美元。分析期内，生物技术最终用途领域的复合年增长率预计为 12.4%。

美国市场预估为2.518亿美元，中国预期复合年增长率为10.5%

预计 2023 年美国X 射线结晶市场规模将达 2.518 亿美元。中国作为世界第二大经济体，预计在2023-2030年分析期间复合年增长率为10.5%，预计到2030年市场规模将达到3.033亿美元。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 10.1% 和 9.4%。在欧洲，德国的复合年增长率预计为 8.0%。

全球 X 光结晶市场 – 主要趋势与驱动因素总结

为什么 X 射线结晶对于科学研究至关重要？

X 射线结晶是一种用于确定结晶原子和分子结构的强大分析技术。它是科学研究的重要工具，特别是在化学、生物学和材料科学等领域。在原子层次上理解分子结构的能力对于药物发现、蛋白质分析和材料开发至关重要。在製药业，X射线结晶经常用于识别生物聚合物的结构，这对于标靶药物的开发很有用。复杂疾病数量的不断增加以及对先进治疗解决方案的需求极大地推动了药物开发和结构生物学对 X 射线结晶的需求。该技术的准确性和有效性使其对于学术和商业研究至关重要。

科技如何增强 X 射线结晶的能力？

最近的技术进步极大地提高了 X 射线结晶的能力。同步加速器辐射和先进检测器等高强度 X 射线源的发展提高了资料收集的分辨率和速度，使得研究最具挑战性的生物结构成为可能。此外，人工智慧和机器学习演算法在资料分析中的整合正在加速复杂结晶资料的解释并减少结构确定所需的时间。由于这些技术进步，X射线结晶的应用范围正在从传统的药物发现和蛋白质工程扩展到奈米技术和量子化学等新领域。

X射线结晶市场面临哪些挑战？

X 射线结晶市场面临多项挑战，特别是在成本、样品製备和技术限制方面。特别是基于同步加速器的X射线结晶等先进系统需要较高的设备和维护成本，这限制了它们只能在资金雄厚的研究机构和大型製药公司中使用。此外，该技术需要高度精製的结晶样品，使得样品製备变得困难且耗时，特别是对于膜蛋白和其他复杂分子。此外，X 射线照射会损坏脆弱的生物检体，影响结果的准确性。这些挑战导致了互补技术的发展，例如冷冻电子显微镜 (cryo-EM)，它可以不受 X 射线结晶的限制来获得类似的结构资讯。

X 射线结晶市场的成长受到多种因素的推动。

X射线结晶市场的成长受到多种因素的推动，包括药物发现和结构生物学需求的增加、X射线源和检测器的技术进步以及对个人化医疗的日益重视。製药业专注于开发复杂疾病的标靶治疗是 X 光结晶的主要驱动力。同步加速器辐射和 X 射线自由电子雷射 (XFEL) 技术的进步正在提高结晶研究的准确性和效率。此外，人工智慧和机器学习在资料分析中的整合正在简化结构确定过程。材料科学领域研究活动的扩大以及新型材料和奈米结构的开发也有助于市场成长，巩固了 X 射线结晶作为科学研究重要工具的作用。

受访企业范例（共41例）

  • 3D Dental
  • Agilent Technologies, Inc.
  • Anton Paar GmbH
  • BioCryst Pharmaceuticals, Inc.
  • Bruker Corporation
  • C4X Discovery
  • Charles River Laboratories International, Inc.
  • Crelux
  • GBC Scientific Equipment Pty., Ltd.
  • Glenbrook Technologies, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP15708

Global X-Ray Crystallography Market to Reach US$2.0 Billion by 2030

The global market for X-Ray Crystallography estimated at US$937.3 Million in the year 2023, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 11.4% over the analysis period 2023-2030. Pharmaceutical End-Use, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$944.5 Million by the end of the analysis period. Growth in the Biotechnology End-Use segment is estimated at 12.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$251.8 Million While China is Forecast to Grow at 10.5% CAGR

The X-Ray Crystallography market in the U.S. is estimated at US$251.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$303.3 Million by the year 2030 trailing a CAGR of 10.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.1% and 9.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.0% CAGR.

Global X-Ray Crystallography Market - Key Trends & Drivers Summarized

What Makes X-Ray Crystallography Vital in Scientific Research?

X-ray crystallography is a powerful analytical technique used to determine the atomic and molecular structure of a crystal. It is an essential tool in scientific research, particularly in fields such as chemistry, biology, and material science. The ability to understand molecular structures at an atomic level is crucial for drug discovery, protein analysis, and materials development. The pharmaceutical industry extensively uses X-ray crystallography to identify the structure of biological macromolecules, which aids in developing targeted drugs. The increasing prevalence of complex diseases and the need for advanced therapeutic solutions have significantly driven the demand for X-ray crystallography in drug development and structural biology. This technique's precision and effectiveness make it indispensable for academic and commercial research.

How Is Technology Enhancing the Capabilities of X-Ray Crystallography?

Recent technological advancements have greatly enhanced the capabilities of X-ray crystallography. The development of high-intensity X-ray sources, such as synchrotron radiation, and advanced detectors have improved the resolution and speed of data collection, making it possible to study even the most challenging biological structures. Moreover, the integration of artificial intelligence and machine learning algorithms in data analysis is accelerating the interpretation of complex crystallographic data, reducing the time required for structural determination. These technological advancements are expanding the scope of X-ray crystallography applications, from traditional drug discovery and protein engineering to new fields such as nanotechnology and quantum chemistry.

What Challenges Does the X-Ray Crystallography Market Face?

The X-ray crystallography market faces several challenges, particularly related to cost, sample preparation, and technological limitations. The high cost of equipment and maintenance, especially for advanced systems like synchrotron-based X-ray crystallography, limits its accessibility to well-funded research institutions and large pharmaceutical companies. Moreover, the technique requires highly purified crystalline samples, which can be difficult and time-consuming to prepare, particularly for membrane proteins and other complex molecules. Additionally, X-ray radiation can damage sensitive biological samples, potentially affecting the accuracy of the results. These challenges are driving the development of complementary techniques such as cryo-electron microscopy (cryo-EM), which can provide similar structural information without some of the limitations of X-ray crystallography.

The Growth in the X-Ray Crystallography Market Is Driven by Several Factors

The growth in the X-ray crystallography market is driven by several factors, including increasing demand in drug discovery and structural biology, technological advancements in X-ray sources and detectors, and the growing emphasis on personalized medicine. The pharmaceutical industry's focus on developing targeted therapies for complex diseases is a major driver for X-ray crystallography. Advances in synchrotron and X-ray free-electron laser (XFEL) technologies are enhancing the precision and efficiency of crystallographic studies. Additionally, the integration of AI and machine learning in data analysis is streamlining the structural determination process. The expansion of research activities in material science and the development of novel materials and nanostructures are also contributing to the market's growth, solidifying X-ray crystallography's role as a critical tool in scientific research.

Select Competitors (Total 41 Featured) -

  • 3D Dental
  • Agilent Technologies, Inc.
  • Anton Paar GmbH
  • BioCryst Pharmaceuticals, Inc.
  • Bruker Corporation
  • C4X Discovery
  • Charles River Laboratories International, Inc.
  • Crelux
  • GBC Scientific Equipment Pty., Ltd.
  • Glenbrook Technologies, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • X-Ray Crystallography - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for X-Ray Crystallography in Drug Discovery and Development
    • Technological Advancements in X-Ray Sources and Detectors Enhancing Accuracy
    • Growing Importance of X-Ray Crystallography in Structural Biology and Protein Analysis
    • Expansion of Crystallography Applications in Material Science and Nanotechnology
    • Development of Automated and High-Throughput Crystallography Systems
    • Impact of AI and Machine Learning in Crystallography Data Analysis
    • Increasing Investments in Academic and Industrial Research Facilities
    • Emergence of Complementary Techniques Such as Cryo-Electron Microscopy
    • Rising Demand for Personalized Medicine Driving Structural Analysis Needs
    • Opportunities for X-Ray Crystallography in Quantum and Molecular Chemistry
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World X-Ray Crystallography Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for X-Ray Crystallography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for X-Ray Crystallography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for X-Ray Crystallography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • X-Ray Crystallography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • X-Ray Crystallography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • X-Ray Crystallography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • X-Ray Crystallography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for X-Ray Crystallography by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for X-Ray Crystallography by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for X-Ray Crystallography by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • X-Ray Crystallography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • X-Ray Crystallography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • X-Ray Crystallography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 44: Rest of Europe Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Rest of Europe Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Rest of Europe 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • X-Ray Crystallography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 47: Asia-Pacific Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Asia-Pacific Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Asia-Pacific 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 50: Rest of World Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of World Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of World 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION